David A. Ziring, MD
4.9
22 Reviews
310-423-7100
Fax: 310-423-1402
4.9
22 Reviews
David A. Ziring, MD
Scheduling
In person visits
Fax: 310-423-1402
Los Angeles
8700 Beverly Blvd
Lower Level
Los Angeles, CA
34.0761098 -118.3799992From You
4.9
22 Reviews
David A. Ziring, MD
Languages
- English,
Gender
Male
Experience
23 Years
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Peds - Gastroenterology
Programs
Cedars-Sinai clinical programs this provider is part of:
4
- Department of Pediatrics
- Digestive Diseases Center
- Inflammatory Bowel Disease Center
- Pediatric IBD Program
Research Areas
Titles
- Associate Director, Pediatric Inflammatory Bowel Disease Program
Education & Training
-
Finch University of Health Sciences
Degrees - Completed 1999
-
Finch University of Health Sciences / Chicago Medical School
Medical School - Completed 1999
Achievements
-
2
Board Certifications
-
6
Publications
Board Certifications
-
Pediatrics
American Board of Pediatrics
-
Peds - Gastroenterology
American Board of Pediatrics
Publications
- Kelley-Quon LI, Jen HC, Ziring DA, Gupta N, Kirschner BS, Ferry GD, Cohen SA, Winter HS, Heyman MB, Gold BD, Shew SB. Predictors of proctocolectomy in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):534-540.
- Ziring DA, Braun J. Pediatric inflammatory bowel disease research: on the cutting-edge. Pediatr Res. 2008 Aug;64(2):119-120.
- Brewer S, McPherson M, Fujiwara D, Turovskaya O, Ziring D, Chen L, Takedatsu H, Targan SR, Wei B, Braun J. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. Gastroenterology. 2008 Sep;135(3):744-755.
- Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008 Feb;126(2):121-36.
- Ziring DA, Wu SS, Mow WS, Martín MG, Mehra M, Ament ME. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children. J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):306-311.
- Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics. 2006 Sep;58(9):714-725.